Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation

Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation

<i>Background and Objectives:</i> Condoliase, a chondroitin sulfate ABC endolyase, is a novel and minimally invasive chemonucleolytic drug for lumbar disc herniation. Despite the growing number of treatments for lumbar disc herniation, the predicting factors for poor outcomes following t...

Full description

Bibliographic Details
Main Authors: Shu Takeuchi, Junya Hanakita, Toshiyuki Takahashi, Tomoo Inoue, Manabu Minami, Izumi Suda, Sho Nakamura, Ryo Kanematsu
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Medicina
Subjects:
lumbar disc herniation
chemonucleolysis
condoliase
chondroitin sulfate ABC endolyase
calcification
ossification
Online Access:https://www.mdpi.com/1648-9144/58/12/1868

Internet

https://www.mdpi.com/1648-9144/58/12/1868

Similar Items